Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery ...

UCB, a global biopharmaceutical company, and XtalPi, a global leader in AI drug discovery, today announced a license agreement ...

There are four phases of a migraine attack, depending on the severity and type of migraine. Prodrome: A few hours to days, ...

Joe DePinto, MBA, discussed the findings of the McKesson 2024 Cell and Gene Therapy Report, providing insight into the ...

It’s more important to practice regularly than to sporadically do longer sessions. 20 minutes a day is a better bet than 60 ...

Lifordi Immunotherapeutics, Inc., a biotech company developing antibody-drug conjugates (ADCs) for the treatment of ...

A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Research into the impact of the COVID pandemic on children and young people with brain tumors has revealed how investigations or treatments were frequently postponed as key people or resources were ...

Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...

Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center have significantly advanced the understanding of genetic alterations in the ...